Site icon OncologyTube

Biologic Rational For Neoadjuvant OVER Adjuvant Approach with IO

Lauren Harshman MD, Co-director of Kidney Cancer Program Dana-Farber Cancer Institute/Harvard Medical School discusses Biologic Rational For Neoadjuvant OVER Adjuvant Approach with IO at the 13th European International Kidney Cancer Symposium 2018 in Prague.

Exit mobile version